Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial
Conclusion:
Perioperative treatment with 40 mg of atorvastatin is useful to decrease the incidence of POAF in the statin-naive patients undergoing isolated heart valve surgery.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - Category: Cardiology Authors: Dehghani, M. R., Kasianzadeh, M., Rezaei, Y., Sepehrvand, N. Tags: Clinical Studies Source Type: research
More News: Atorvastatin Calcium | Atrial Fibrillation | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Clinical Trials | Drugs & Pharmacology | Electrocardiogram | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Intensive Care | Lipitor | Statin Therapy | Study | Zivast
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024